Ambalal Sarabhai Enterprises Limited (AMBALALSA.BO)
INR 39.16
(0.72%)
INR 39.16
(0.72%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 280.83 Million INR | -30.25% |
| 2022 | 552.53 Million INR | 5.85% |
| 2021 | 521.97 Million INR | -2.18% |
| 2020 | 533.58 Million INR | 3.84% |
| 2019 | 513.86 Million INR | 1.66% |
| 2018 | 505.46 Million INR | -19.04% |
| 2017 | 624.35 Million INR | -1.02% |
| 2016 | 630.81 Million INR | -24.14% |
| 2015 | 831.57 Million INR | 38.61% |
| 2014 | 599.94 Million INR | 6.7% |
| 2013 | 562.25 Million INR | 0.87% |
| 2012 | 557.41 Million INR | 0.0% |
| 2009 | 11.5 Million INR | 213.51% |
| 2008 | -10.13 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 94.28 Million INR | -32.3% |
| 2023 Q2 | 166.47 Million INR | 8.84% |
| 2023 Q3 | 94.4 Million INR | -43.29% |
| 2023 Q4 | 106.56 Million INR | 12.88% |
| 2023 FY | 385.37 Million INR | -30.25% |
| 2023 Q1 | 152.95 Million INR | 46.49% |
| 2022 Q2 | 150.93 Million INR | -0.44% |
| 2022 FY | 552.53 Million INR | 5.85% |
| 2022 Q1 | 151.59 Million INR | 60.23% |
| 2022 Q3 | 145.6 Million INR | -3.53% |
| 2022 Q4 | 104.4 Million INR | -28.29% |
| 2021 Q4 | 94.61 Million INR | -28.27% |
| 2021 Q3 | 131.89 Million INR | -12.47% |
| 2021 FY | 521.97 Million INR | -2.18% |
| 2021 Q2 | 150.68 Million INR | 4.01% |
| 2021 Q1 | 144.87 Million INR | 36.96% |
| 2020 Q4 | 105.78 Million INR | -35.36% |
| 2020 FY | 533.58 Million INR | 3.84% |
| 2020 Q3 | 163.64 Million INR | 12.33% |
| 2020 Q2 | 145.67 Million INR | 22.96% |
| 2020 Q1 | 118.48 Million INR | 40.55% |
| 2019 Q1 | 138.28 Million INR | 104.04% |
| 2019 FY | 513.86 Million INR | 1.66% |
| 2019 Q3 | 150.98 Million INR | 7.61% |
| 2019 Q4 | 84.29 Million INR | -44.17% |
| 2019 Q2 | 140.3 Million INR | 1.46% |
| 2018 Q3 | 145.82 Million INR | -2.22% |
| 2018 Q2 | 149.13 Million INR | 4.48% |
| 2018 Q1 | 142.73 Million INR | -29.02% |
| 2018 Q4 | 67.77 Million INR | -53.52% |
| 2018 FY | 505.46 Million INR | -19.04% |
| 2017 FY | 624.35 Million INR | -1.02% |
| 2017 Q4 | 201.1 Million INR | 44.97% |
| 2017 Q3 | 138.71 Million INR | -4.5% |
| 2017 Q2 | 145.25 Million INR | -0.46% |
| 2017 Q1 | 145.91 Million INR | 0.0% |
| 2016 FY | 630.81 Million INR | -24.14% |
| 2015 FY | 831.57 Million INR | 38.61% |
| 2014 FY | 599.94 Million INR | 6.7% |
| 2013 FY | 562.25 Million INR | 0.87% |
| 2012 FY | 557.41 Million INR | 0.0% |
| 2009 FY | 11.5 Million INR | 213.51% |
| 2008 FY | -10.13 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| ANG Lifesciences India Limited | 219.92 Million INR | -27.692% |
| Add-Shop E-Retail Limited | 146.52 Million INR | -91.66% |
| Bacil Pharma Limited | 1.87 Million INR | -14882.528% |
| BDH Industries Limited | 57.03 Million INR | -392.41% |
| Beryl Drugs Limited | 93.77 Million INR | -199.486% |
| Cian Healthcare Limited | 59.19 Million INR | -374.385% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | -14323.78% |
| Concord Drugs Limited | 91.83 Million INR | -205.81% |
| Deccan Health Care Limited | 36.24 Million INR | -674.877% |
| DECIPHER LABS LIMITED | 277.6 Million INR | -1.164% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | -112.078% |
| Gujarat Themis Biosyn Limited | 156.84 Million INR | -79.048% |
| Hindustan Bio Sciences Limited | 2.6 Million INR | -10666.235% |
| Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 35.767% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | -1605.417% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | -12.814% |
| Panchsheel Organics Limited | 68.15 Million INR | -312.023% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | -87.82% |
| Parnax Lab Limited | 80.59 Million INR | -248.46% |
| Makers Laboratories Limited | 83.1 Million INR | -237.927% |
| Medi-Caps Limited | 93.11 Million INR | -201.586% |
| MedPlus Health Services Limited | 2.42 Billion INR | 88.415% |
| Phaarmasia Limited | 50.52 Million INR | -455.815% |
| Parmax Pharma Limited | 99.31 Million INR | -182.762% |
| Patidar Buildcon Limited | 1.81 Million INR | -15406.957% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | -34.448% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -18327.231% |
| Trident Lifeline Limited | 46.87 Million INR | -499.157% |
| Tyche Industries Limited | 182.04 Million INR | -54.267% |
| Vivanza Biosciences Limited | 4.55 Million INR | -6065.335% |
| PRAVEG LIMITED | 77.18 Million INR | -263.856% |
| Smruthi Organics Limited | 261.73 Million INR | -7.296% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | -781.536% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | -92.23% |
| Sastasundar Ventures Limited | 846.78 Million INR | 66.836% |
| Transchem Limited | 8.47 Million INR | -3214.422% |
| Trinity League India Limited | -1.08 Million INR | 25959.208% |
| Vikram Thermo (India) Limited | 104.27 Million INR | -169.315% |
| Vista Pharmaceuticals Limited | 20.16 Million INR | -1292.596% |
| Sunil Healthcare Limited | 438.1 Million INR | 35.899% |
| Syschem (India) Limited | 64.13 Million INR | -337.895% |
| Zenith Healthcare Limited | 45.97 Million INR | -510.794% |
| Zenlabs Ethica Limited | 57.89 Million INR | -385.07% |
| Mercury Laboratories Limited | 217.24 Million INR | -29.271% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | -2183.086% |
| Vasundhara Rasayans Limited | 145.5 Million INR | -93.002% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | -52.558% |
| Roopa Industries Limited | 24.63 Million INR | -1039.968% |
| PANJON LTD. | 33.77 Million INR | -731.377% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | -267.128% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -262358.879% |
| Anuh Pharma Limited | 263.04 Million INR | -6.762% |
| Crestchem Limited | 50.8 Million INR | -452.789% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | -6397.709% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | -31.907% |
| Fredun Pharmaceuticals Limited | 360.45 Million INR | 22.091% |
| Trimurthi Limited | 4.81 Million INR | -5737.269% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | -238.135% |
| Norris Medicines Limited | 18.2 Million INR | -1442.591% |
| Veerhealth Care Limited | 15.38 Million INR | -1725.712% |
| Lactose (India) Limited | 111.66 Million INR | -151.501% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | -1080.955% |
| Gennex Laboratories Limited | 130.37 Million INR | -115.399% |
| Denis Chem Lab Limited | 453.36 Million INR | 38.057% |
| Colinz Laboratories Limited | 31.19 Million INR | -800.157% |
| Godavari Drugs Limited | 359.01 Million INR | 21.776% |
| Zenotech Laboratories Limited | 94.82 Million INR | -196.167% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | -169.68% |
| Bharat Parenterals Limited | 255.97 Million INR | -9.709% |
| Coral Laboratories Limited | 189.75 Million INR | -47.994% |
| Evoq Remedies Limited | 4.51 Million INR | -6117.202% |
| Kerala Ayurveda Limited | 399.64 Million INR | 29.73% |
| KOBO BIOTECH LIMITED | 2.48 Million INR | -11223.831% |
| Natural Capsules Limited | 444.7 Million INR | 36.849% |
| Auro Laboratories Limited | 157.37 Million INR | -78.446% |